Follow
Ivan Blasutig
Ivan Blasutig
Clinical Biochemist, Children's Hospital of Eastern Ontario
Verified email at uhn.ca
Title
Cited by
Cited by
Year
Cancer immunotherapy: the beginning of the end of cancer?
S Farkona, EP Diamandis, IM Blasutig
BMC medicine 14, 1-18, 2016
13392016
Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes
N Jones, IM Blasutig, V Eremina, JM Ruston, F Bladt, H Li, H Huang, ...
Nature 440 (7085), 818-823, 2006
5592006
The long journey of cancer biomarkers from the bench to the clinic
MP Pavlou, EP Diamandis, IM Blasutig
Clinical chemistry 59 (1), 147-157, 2013
1842013
Validation of biomarkers that complement CA19. 9 in detecting early pancreatic cancer
A Chan, I Prassas, A Dimitromanolakis, RE Brand, S Serra, EP Diamandis, ...
Clinical Cancer Research 20 (22), 5787-5795, 2014
1392014
Nck proteins maintain the adult glomerular filtration barrier
N Jones, LA New, MA Fortino, V Eremina, J Ruston, IM Blasutig, L Aoudjit, ...
Journal of the American Society of Nephrology 20 (7), 1533-1543, 2009
1232009
Phosphorylated YDXV motifs and Nck SH2/SH3 adaptors act cooperatively to induce actin reorganization
IM Blasutig, LA New, A Thanabalasuriar, TK Dayarathna, M Goudreault, ...
Molecular and cellular biology 28 (6), 2035-2046, 2008
1232008
Non-canonical interaction of phosphoinositides with pleckstrin homology domains of Tiam1 and ArhGAP9
DFJ Ceccarelli, IM Blasutig, M Goudreault, Z Li, J Ruston, T Pawson, ...
Journal of biological chemistry 282 (18), 13864-13874, 2007
1122007
Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues
H Kosanam, I Prassas, CC Chrystoja, I Soleas, A Chan, ...
Molecular & Cellular Proteomics 12 (10), 2820-2832, 2013
1102013
Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues
H Kosanam, I Prassas, CC Chrystoja, I Soleas, A Chan, ...
Molecular & Cellular Proteomics 12 (10), 2820-2832, 2013
1102013
Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19. 9
S Makawita, A Dimitromanolakis, A Soosaipillai, I Soleas, A Chan, ...
BMC cancer 13, 1-11, 2013
782013
Strategies for discovering novel pancreatic cancer biomarkers
A Chan, EP Diamandis, IM Blasutig
Journal of proteomics 81, 126-134, 2013
702013
Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobasŪ 6000 analyzer—A CALIPER pilot study
V Kulasingam, BP Jung, IM Blasutig, S Baradaran, MK Chan, M Aytekin, ...
Clinical biochemistry 43 (13-14), 1045-1050, 2010
672010
Candidate recommendations for protein electrophoresis reporting from the Canadian society of clinical chemists monoclonal gammopathy working group
RA Booth, CR McCudden, CM Balion, IM Blasutig, I Bouhtiauy, ...
Clinical Biochemistry 51, 10-20, 2018
572018
False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125
I Prassas, D Brinc, S Farkona, F Leung, A Dimitromanolakis, CC Chrystoja, ...
Clinical Chemistry 60 (2), 381-388, 2014
492014
Definitive characterization of CA 19-9 in resectable pancreatic cancer using a reference set of serum and plasma specimens
BB Haab, Y Huang, S Balasenthil, K Partyka, H Tang, M Anderson, ...
PLoS One 10 (10), e0139049, 2015
422015
Analytical evaluation of the VITROSŪ 5600 Integrated System in a pediatric setting and determination of pediatric reference intervals
IM Blasutig, B Jung, V Kulasingam, S Baradaran, Y Chen, MK Chan, ...
Clinical biochemistry 43 (13-14), 1039-1044, 2010
402010
Determination of the Plk4/Sak consensus phosphorylation motif using peptide spots arrays
GC Leung, CSW Ho, IM Blasutig, JM Murphy, F Sicheri
FEBS letters 581 (1), 77-83, 2007
392007
Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer
D Korbakis, A Dimitromanolakis, I Prassas, GJ Davis, E Barber, ...
British journal of cancer 113 (3), 484-491, 2015
352015
Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity
AA Venner, D Ibaņez, DD Gladman, MB Urowitz, A MacKinnon, ...
Clinical biochemistry 46 (4-5), 317-320, 2013
342013
Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer
AWS Fung, MJ Knauer, IM Blasutig, DA Colantonio, V Kulasingam
F1000Research 6, 2017
312017
The system can't perform the operation now. Try again later.
Articles 1–20